Imricor Medical Systems Profit Margin

Imricor Medical Systems (IMR.AX) currently reports a profit margin of -8672.36% as of June 2026. That compares with -2848.1% in the prior-year period — down 204.5% year over year. That is below the sector sector average of 13.23%. Use the charts on this page to explore Imricor Medical Systems's profit margin history and peer comparisons.

Imricor Medical Systems's profit margin decreased from -2848.1% to -8672.36% — a 204.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Imricor Medical Systems's profit margin of -8672.36% is lower than the its sector sector average of 13.23%. That is roughly 65669.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Imricor Medical Systems's current -8672.36% should be judged against industry norms (sector average: 13.23%) and against IMR.AX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -8672.36%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for Imricor Medical Systems, and consider following IMR.AX for alerts when major investors trade the stock.